Maurice Slevin

From WikiAlpha
Jump to: navigation, search
Maurice Slevin
Nationality British
Occupation Medical doctor

Dr. Maurice Slevin is a British oncologist and researcher, originally from South Africa.

He is known as a researcher into the schedule dependency of chemotherapy as well as for carrying out research in psychosocial oncology. He joined Doctor Vicky Clement-Jones in setting up Cancerbackup,[1][2] a U.K. cancer charity in 1985 and chaired the charity for over 20 years. He is also a founding partner and board member of Leaders in Oncology Care (formerly called London Oncology Clinic). His h-index is 56, per Google Scholar.[3]

Education and background

In 1973, Dr. Slevin graduated from the University of Cape Town (South Africa) with a MbChB degree. He carried out his internal medicine registrar training at Groot-Schuur Hospital in Cape Town.

Dr. Slevin obtained his MRCP postgraduate degree in London in 1978 and his FRCP in 1989. He undertook his oncology registrar training at St. Bartholomew’s and Homerton Hospitals in London. He obtained his Specialist Accreditation in Medical Oncology in 1982.

His research doctorate from the University of Cape Town was on the clinical pharmacology of Cytosine Arabinoside, graduating in 1984.


Dr. Slevin became as a consultant medical oncologist for the UK's National Health Service at St. Bartholomew’s Hospital and Homerton Hospital in 1982 and specialised in breast, ovarian, lung and gastrointestinal cancers.

Dr. Slevin also became a Fellow of the Royal College of Physicians of London (FRCP) in 1989 while he was working at the National Health Service.

In 2005, Dr. Slevin co-founded the London Oncology Clinic (LOC), which now has seven clinics with more than 70 oncology specialists.[4] In 2010 the Hospital Corporation of America (HCA) took over the LOC and the name was changed to Leaders in Oncology Care.

Cancer research

While working as a consultant medical oncologist at St Bartholomew’s and Homerton Hospitals, Dr. Slevin founded and directed a clinical pharmacology laboratory investigating schedule dependency of Etoposide in small-cell lung cancer.[5]

He also conducted research on the clinical pharmacology of cytosine arabinoside[6] and performed early research on morphine’s major active metabolites.[7] Dr. Slevin also conducted research on attitudes to chemotherapy amongst cancer patients.[8]

Dr. Slevin also supervised several doctoral thesis.

Cancerbackup and Cancer Research Campaign

In 1985, Dr. Slevin assisted Dr Vicky Clement-Jones to set up the cancer charity Cancerbackup, and was the board chairman from 1987 until 2008. In 2008, Cancerbackup merged with Macmillan Cancer Care. Dr Slevin was a trustee of Macmillan Cancer Care from 2008 to 2010.

Additionally, from 1995-2000, Dr. Slevin was a trustee of Cancer Research Campaign (CRC), and was also the chair of CRC’s education and psychosocial committee.

Criticism of the NHS

Starting in the early 2000s, Dr. Slevin has criticised the way the NHS was managed. He published an article critical of NHS management,[9] suggesting that the NHS was hampered by excessive bureaucracy and that there were nearly as many NHS managers as nurses. This generated several editorials.[10][11][12] However, the NHS federation disagreed with Slevin's claims.[13] He also became the co-founder of Doctors for Reform,[14] an organization that proposed reforms for the NHS, such as a social insurance funding model.


Dr. Slevin has edited 3 medical books and written 2 books for cancer patients.

He has also been the author or co-author of more than 150 peer reviewed publications,[15] several editorials, and various book chapters. His H index, according to Google Scholar is 56.[3]


  1. "BACUP--the first two years: evaluation of a national cancer information service". BMJ 297 (6649): 669–72. September 1988. doi:10.1136/bmj.297.6649.669. PMC 1834344. PMID 3140928. 
  2. Cancerbackup: A brief history.
  3. 3.0 3.1 "Maurice Slevin". 
  4. "Leaders in Oncology Care (LOC) awarded CQC’s highest rating for cancer care services at four London locations - CQC Public Website". 2021-12-10. 
  5. "Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid". J Clin Oncol 1 (9): 546–51. September 1983. doi:10.1200/JCO.1983.1.9.546. PMID 6583325. 
  6. "Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid". J Clin Oncol 1 (9): 546–51. September 1983. doi:10.1200/JCO.1983.1.9.546. PMID 6583325. 
  7. "Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide". Clin Pharmacol Ther 47 (1): 12–9. January 1990. doi:10.1038/clpt.1990.2. PMID 2295214. 
  8. "Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public". BMJ 300 (6737): 1458–60. June 1990. doi:10.1136/bmj.300.6737.1458. PMC 1663147. PMID 2379006. 
  10. "NHS could implode say doctors". 2003-02-03. 
  11. Carvel, John (2003-02-04). "NHS on brink of implosion, claims leading specialist". 
  12. Hall, Celia (2003-02-04). "NHS is crushed by red tape, say consultants". 
  13. (in en) Managers fight back over consultants claims, 2003-02-06,, retrieved 2021-11-26 
  14. "Doctors for Reform". 2010-11-08. 
  15. Maurice L. Slevin. ResearchGate.